ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 530,72
0,00%
Dow Jones
39 164,06
0,09%
DAX
18 210,55
0,26%
Brent Oil
85,715
0,35%
Bitcoin
61 443,84
-0,27%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Enveric Biosciences Inc (ENVB)

  7. Enveric Biosciences Inc (ENVB) Actualités

ENVB Enveric Biosciences Inc

0,6201
-0,0193 (-3,02%)
28 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Enveric Biosciences Inc ENVB NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,0193 -3,02% 0,6201 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
0,659 0,61 0,659 0,6296 0,6394
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
25/6/202414:00BWEnveric Biosciences Provides Strategic Outlook and Pipeline..
04/6/202400:58EDGAR2Form 3 - Initial statement of beneficial ownership of..
30/5/202414:00BWEnveric Biosciences to Participate in BIO International..
29/5/202422:15EDGAR2Form 8-K - Current report
23/5/202414:00EDGAR2Form 8-K - Current report
17/5/202423:25EDGAR2Form 8-K - Current report
15/5/202412:00BWEnveric Biosciences Reports First Quarter 2024 Financial and..
14/5/202414:00BWEnveric Biosciences Signs $66.5 Million Non-Binding Term..
08/5/202413:00BWEnveric Biosciences Announces Signing of Non-Binding Term..
26/3/202412:00BWEnveric Biosciences Reports Financial Results and Provides..
19/3/202412:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
12/3/202412:00BWEnveric Biosciences Announces New Patent Issuances..
11/3/202417:35EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
11/3/202413:00EDGAR2Form 8-K - Current report
29/2/202413:00EDGAR2Form 8-K - Current report
29/2/202413:00BWEnveric Biosciences Signs Non-Binding Term Sheets to Pursue..
26/2/202422:53EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/2/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/2/202414:00BWEnveric Biosciences Agrees to Sell Cancer-Targeting..
21/2/202414:05EDGAR2Form 8-K - Current report
21/2/202414:00BWEnveric Biosciences Unveils Library of Preclinical Compounds..
14/2/202421:36EDGAR2Form SC 13G - Statement of acquisition of beneficial..
09/2/202414:05EDGAR2Form 8-K - Current report
06/2/202416:17EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
05/2/202423:09EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
24/1/202414:05EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
11/1/202422:43EDGAR2Form S-3 - Registration statement under Securities Act of..
08/1/202422:42EDGAR2Form 8-K - Current report
03/1/202414:05EDGAR2Form 8-K - Current report
29/12/202322:43EDGAR2Form 8-K - Current report
29/12/202314:52BWEnveric Biosciences Announces Exercise of Warrants and..
28/12/202314:05EDGAR2Form 8-K - Current report
28/12/202314:00BWEnveric Biosciences Selects EB-003 as Lead Drug Candidate..
27/12/202314:05EDGAR2Form 8-K - Current report
27/12/202314:00BWEnveric Biosciences Reports Year End Progress for..
20/12/202314:00BWEnveric Biosciences to Participate in Biotech Showcase 2024..
06/12/202322:00EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
05/12/202314:05EDGAR2Form 8-K - Current report
05/12/202314:00BWEnveric Biosciences Selects Development Candidates from..
01/12/202322:31EDGAR2Form S-1/A - General form for registration of securities..
29/11/202314:18EDGAR2Form 8-K - Current report
29/11/202314:00BWEnveric Biosciences Receives Notice of Allowance from USPTO..
27/11/202314:00BWEnveric Biosciences Announces Manuscript Describing the..
24/11/202314:00BWEnveric Biosciences Announces Presentation of Two Posters at..
22/11/202322:30EDGAR2Form 8-K - Current report
13/11/202322:10EDGAR2Form 8-K - Current report
13/11/202322:06EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
13/11/202322:01BWEnveric Biosciences Reports Third Quarter 2023 Corporate and..
06/11/202314:05EDGAR2Form 8-K - Current report

Dernières Valeurs Consultées

NASDAQ
ENVB
Enveric Biosciences
BOV
BCHQ39Q
Global X Funds
UNSW3
COCETH
CryptoOracle Collective
BIT
S32535
Societe Generale Effekten
BIT
SGEN5L
SG Issuer Societe Generale
BIT
P20LW2
NLBNPIT20LW2 20240621 38...
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés